L. Carlton

The Effects of Epoprostenol on Drug Disposition II: A Pilot Study of the Pharmacokinetics of Furosemide with and without Epoprostenol in Patients with Congestive Heart Failure

V. Schmith, L. D. Carlton, C. Mattson, 1996, Journal of clinical pharmacology.

The Effects of Epoprostenol on Drug Disposition I: A Pilot Study of the Pharmacokinetics of Digoxin with and without Epoprostenol in Patients with Congestive Heart Failure

V. Schmith, C. Mattson, J. Patterson, 1996, Journal of clinical pharmacology.

Physiologic pharmacokinetic modeling of gastrointestinal blood flow as a rate-limiting step in the oral absorption of digoxin: implications for patients with congestive heart failure receiving epoprostenol.

K. Brouwer, L. D. Carlton, G. Pollack, 1996, Journal of pharmaceutical sciences.